These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31121385)

  • 1. Effectiveness of Managing Diabetes During Ramadan Conversation Map intervention: A difference-in-differences (self-comparison) design.
    Srulovici E; Leventer-Roberts M; Curtis B; He X; Hoshen M; Rotem M; Bachrach A; Reges O; Key C; Levin-Iaina N; Strizek A; Feldman B
    Int J Nurs Stud; 2019 Jul; 95():65-72. PubMed ID: 31121385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Use of the Fasting Algorithm for Singaporeans With Type 2 Diabetes (FAST) During Ramadan: A Prospective, Multicenter, Randomized Controlled Trial.
    Lum ZK; Khoo ZR; Toh WYS; Kamaldeen SAK; Shakoor A; Tsou KYK; Chew DEK; Dalan R; Kwek SC; Othman N; Lian JX; Bte Sunari RN; Lee JY
    Ann Fam Med; 2020 Mar; 18(2):139-147. PubMed ID: 32152018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of focused pre-Ramadan education on metabolic and glycaemic parameters in patients with type 2 diabetes mellitus.
    El Toony LF; Hamad DA; Omar OM
    Diabetes Metab Syndr; 2018 Sep; 12(5):761-767. PubMed ID: 29729978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus.
    Ibrahim M; Barker MM; Ahmad E; Ahmed A; Annabi FA; Ba-Essa EM; Davies MJ; Houeiss P; Iraqi H; Masood SN; Mimouni-Zerguini S; Shaikh S; Tantawi H; Tuomilehto J
    Diabetes Metab Res Rev; 2023 Mar; 39(3):e3604. PubMed ID: 36547366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge of diabetes mellitus and safe practices during Ramadan fasting among Muslim patients with diabetes mellitus in Singapore.
    Zainudin SB; Ang DY; Soh AW
    Singapore Med J; 2017 May; 58(5):246-252. PubMed ID: 27121922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Structured Nutrition Therapy for Ramadan with Standard Care in Type 2 Diabetes Patients.
    Mohd Yusof BN; Wan Zukiman WZHH; Abu Zaid Z; Omar N; Mukhtar F; Yahya NF; Shahar ASM; Hasbullah FY; Liu Xin Yi R; Marczewska A; Hamdy O
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care.
    Alawadi F; Rashid F; Bashier A; Abdelgadir E; Al Saeed M; Abuelkheir S; Khalifa A; Al Sayyah F; Bachet F; Elsayed M; Abdallah K; Hassanein M
    Diabetes Res Clin Pract; 2019 May; 151():305-312. PubMed ID: 30880094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current state of knowledge, perception and practice in diabetes management during fasting in Ramadan by healthcare professionals.
    Zainudin SB; Hussain AB
    Diabetes Metab Syndr; 2018 May; 12(3):337-342. PubMed ID: 29305048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of vildagliptin relative to sulfonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the Middle East: the VIRTUE study.
    Hassoun AA; Al-Arouj M; Ibrahim M
    Curr Med Res Opin; 2017 Jan; 33(1):161-167. PubMed ID: 27684469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of contextual education for self-management in Thai Muslims with type 2 diabetes mellitus during Ramadan.
    Susilparat P; Pattaraarchachai J; Songchitsomboon S; Ongroongruang S
    J Med Assoc Thai; 2014 Aug; 97 Suppl 8():S41-9. PubMed ID: 25518292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudinal determinants of fasting in type 2 diabetes mellitus patients during Ramadan.
    Fatim J; Karoli R; Chandra A; Naqvi N
    J Assoc Physicians India; 2011 Oct; 59():630-4. PubMed ID: 22479742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study.
    Salti I; Bénard E; Detournay B; Bianchi-Biscay M; Le Brigand C; Voinet C; Jabbar A;
    Diabetes Care; 2004 Oct; 27(10):2306-11. PubMed ID: 15451892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effectiveness of the Diabetes Conversation Map™ Program on health outcomes: A case-control retrospective cohort study.
    Srulovici E; Leventer-Roberts M; Curtis B; He X; Hoshen M; Rotem M; Reges O; Key C; Levin-Iaina N; Strizek A; Feldman B
    J Adv Nurs; 2020 Sep; 76(9):2299-2310. PubMed ID: 32496588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of optimum diabetes care on the safety of fasting in Ramadan in adult patients with type 2 diabetes mellitus on insulin therapy.
    Bashier AMK; Hussain AKB; Alawadi F; Alsayyah F; Alsaeed M; Rashid F; Abdelgadir E; Bachet F; Abuelkheir S; Elsayed M; Hassanein M
    Diabetes Res Clin Pract; 2019 Apr; 150():301-307. PubMed ID: 30768940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan.
    Bravis V; Hui E; Salih S; Mehar S; Hassanein M; Devendra D
    Diabet Med; 2010 Mar; 27(3):327-31. PubMed ID: 20536496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of a patient-oriented education system for diabetes management.
    Lee TI; Yeh YT; Liu CT; Chen PL
    Int J Med Inform; 2007 Sep; 76(9):655-63. PubMed ID: 16815741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study.
    Hassanein M; Hanif W; Malik W; Kamal A; Geransar P; Lister N; Andrews C; Barnett A
    Curr Med Res Opin; 2011 Jul; 27(7):1367-74. PubMed ID: 21568833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM).
    Hassanein M; Al Awadi FF; El Hadidy KES; Ali SS; Echtay A; Djaballah K; Dessapt-Baradez C; Khazaal FAK; Abu-Hijleh MO; Al Shaikh A; Gharbi MEH; Shehadeh N; Bennakhi A; Al Arouj M
    Diabetes Res Clin Pract; 2019 May; 151():275-284. PubMed ID: 30825560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycaemic Control Of Type 2 Diabetic Patients During Ramazan Fasting.
    Malik U; Mahmood N; Khan KA; Hameed M; Randhawa FA; Salman S; Riaz A; Waheed K; Rasheed A
    J Ayub Med Coll Abbottabad; 2017; 29(1):102-106. PubMed ID: 28712186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM).
    Lessan N; Hannoun Z; Hasan H; Barakat MT
    Diabetes Metab; 2015 Feb; 41(1):28-36. PubMed ID: 25497966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.